MedTrace Logo

Safety and Hemostatic Efficacy of Fibrin Fleece in Partial Nephrectomy

NCT00598130 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2009-11-06

No results posted yet for this study

Summary

This is a prospective, randomized, single blind, standard care- controlled study, which will include a total of 30 patients divided into two treatment arms: First are: patents who will be treated in accordance with standard of care. Second arm: patients for which the Fibrin Fleece will be applied directly on the active bleeding site.

Conditions

  • Hemostatic Techniques
  • Nephrectomy

Interventions

BIOLOGICAL

Fleece

Fibrin Patch

Sponsors & Collaborators

  • OMRIX Biopharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Yoram Dekel, MD · Rabin MC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2008-11-30
Completion
2009-02-28

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00598130 on ClinicalTrials.gov